Journal of Clinical Epidemiology
Volume 52, Issue 12 , Pages 1187-1195, December 1999

Effect of Hormone Replacement Therapy on the Validity of the Friedewald Equation in Postmenopausal Women:

The Postmenopausal Estrogen/Progestins Interventions (PEPI) Trial

  • Claudine Legault

      Affiliations

    • Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC USA
    • Corresponding Author InformationAddress for correspondence: Claudine Legault, PhD, Dept. of Public Health Sciences, Wake Forest University School of Medicine, Medical Center Blvd., Winston Salem, NC 27157-1063.
  • ,
  • Marcia L Stefanick

      Affiliations

    • Stanford Center for Research in Disease Prevention, Palo Alto, CA USA
  • ,
  • Valery T Miller

      Affiliations

    • George Washington University, Washington, DC USA
  • ,
  • Santica M Marcovina

      Affiliations

    • Department of Medicine, University of Washington, Seattle, WA USA
  • ,
  • Helmut G Schrott

      Affiliations

    • Department of Preventive Medicine and Environmental Health, University of Iowa College of Medicine, Iowa City, IA USA

Accepted 7 May 1999.

Abstract 

The Friedewald equation is often used to estimate low-density lipoprotein cholesterol (LDL-C). Hormone therapy is known to raise triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) and alter lipid contents of lipoproteins. We compared Friedewald estimated LDL-C to measured LDL-C in PEPI participants on placebo or four different hormone treatment groups. At baseline, the 0.2 coefficient for triglyceride (TG) was accurate for all five treatment groups. Among women who took >80% of their pills and whose TG was <4.5 mmol/l (400 mg/dl), LDL-C was underestimated for 69–82% of the participants in the active treatment groups, compared to 50% in the placebo group. After 3 years of therapy, the TG coefficient that offered a better fit of the Friedewald equation in the active treatment groups was 0.39 for the equation in mmol/l (0.17 for the equation in mg/dl). Using this coefficient is clearly warranted for greater accuracy in research studies.

Keywords:  Postmenopause, lipoproteins, lipids, LDL-C, Friedewald, hormone replacement therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0895-4356(99)00107-9

Journal of Clinical Epidemiology
Volume 52, Issue 12 , Pages 1187-1195, December 1999